Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657655 · ClinicalTrials.gov registry record · NA
Kinesia 360 Parkinson's Monitoring Study
A NA study, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02657655: Completed NA study, sponsored by Great Lakes NeuroTechnologies.
NCT02657655 is a NA study that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02657655, a NA study, has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Kinesia 360 is an ambulatory symptom monitoring device for Parkinson's Disease (PD). The aim of this study is to investigate the impact, validation, and usability of the Kinesia 360 system.
Interventions
- DEVICE Kinesia 360
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-02 |
| Phase | NA |
What the finished NCT02657655 record still lists
NCT02657655 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Kinesia 360 is the first listed.
NCT02657655 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02657655 about?
NCT02657655 is a clinical study titled "Kinesia 360 Parkinson's Monitoring Study". Kinesia 360 is an ambulatory symptom monitoring device for Parkinson's Disease (PD). The aim of this study is to investigate the impact, validation, and usability of the Kinesia 360 system.
What is the current status of trial NCT02657655?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-01. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02657655?
The interventions under investigation include: Kinesia 360 (DEVICE).
Who is sponsoring clinical trial NCT02657655?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02657655's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia